These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 27881002

  • 1. Expression of orphan GPR56 correlates with tumor progression in human epithelial ovarian cancer.
    Liu Z, Huang Z, Yang W, Li Z, Xing S, Li H, Hu B, Li P.
    Neoplasma; 2017; 64(1):32-39. PubMed ID: 27881002
    [Abstract] [Full Text] [Related]

  • 2. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer.
    Ma M, Yu N.
    Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213
    [Abstract] [Full Text] [Related]

  • 3. YKL40/Integrin β4 Axis Induced by the Interaction between Cancer Cells and Tumor-Associated Macrophages Is Involved in the Progression of High-Grade Serous Ovarian Carcinoma.
    Yamanaka K, Koma YI, Urakami S, Takahashi R, Nagamata S, Omori M, Torigoe R, Yokoo H, Nakanishi T, Ishihara N, Tsukamoto S, Kodama T, Nishio M, Shigeoka M, Yokozaki H, Terai Y.
    Int J Mol Sci; 2024 Oct 01; 25(19):. PubMed ID: 39408927
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Expression of Placenta Growth Factor Is Associated with Unfavorable Prognosis of Advanced-Stage Serous Ovarian Cancer.
    Meng Q, Duan P, Li L, Miao Y.
    Tohoku J Exp Med; 2018 Apr 01; 244(4):291-296. PubMed ID: 29643276
    [Abstract] [Full Text] [Related]

  • 8. Expression of G Protein-coupled Receptor 56 Is an Unfavorable Prognostic Factor in Osteosarcoma Patients.
    Chen Z, Gao P, Li Z.
    Tohoku J Exp Med; 2016 Jul 01; 239(3):203-11. PubMed ID: 27396430
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma.
    Chang B, Meng J, Zhu H, Du X, Sun L, Wang L, Li S, Yang G.
    Diagn Pathol; 2018 Nov 14; 13(1):87. PubMed ID: 30428884
    [Abstract] [Full Text] [Related]

  • 10. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
    Mao YN, Zeng LX, Li YH, Liu YZ, Wu JY, Li L, Wang Q.
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct 25; 52(10):687-696. PubMed ID: 29060967
    [Abstract] [Full Text] [Related]

  • 11. Up-regulation of cadherin 17 and down-regulation of homeodomain protein CDX2 correlate with tumor progression and unfavorable prognosis in epithelial ovarian cancer.
    Huang LP, Yu YH, Sheng C, Wang SH.
    Int J Gynecol Cancer; 2012 Sep 25; 22(7):1170-6. PubMed ID: 22810971
    [Abstract] [Full Text] [Related]

  • 12. LGR4 overexpression is associated with clinical parameters and poor prognosis of serous ovarian cancer.
    Zeng Z, Ji N, Yi J, Lv J, Yuan J, Lin Z, Liu L, Feng X.
    Cancer Biomark; 2020 Sep 25; 28(1):65-72. PubMed ID: 32176632
    [Abstract] [Full Text] [Related]

  • 13. Fibroblast growth factor 19 is correlated with an unfavorable prognosis and promotes progression by activating fibroblast growth factor receptor 4 in advanced-stage serous ovarian cancer.
    Hu L, Cong L.
    Oncol Rep; 2015 Nov 25; 34(5):2683-91. PubMed ID: 26323668
    [Abstract] [Full Text] [Related]

  • 14. EphA8 is a prognostic marker for epithelial ovarian cancer.
    Liu X, Xu Y, Jin Q, Wang W, Zhang S, Wang X, Zhang Y, Xu X, Huang J.
    Oncotarget; 2016 Apr 12; 7(15):20801-9. PubMed ID: 26989075
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer.
    Ma RQ, Tang ZJ, Ye X, Cheng HY, Sun KK, Chang XH, Cui H.
    Arch Gynecol Obstet; 2018 May 12; 297(5):1235-1244. PubMed ID: 29428978
    [Abstract] [Full Text] [Related]

  • 16. G Protein-Coupled Estrogen Receptor Correlates With Dkk2 Expression and Has Prognostic Impact in Ovarian Cancer Patients.
    Fraungruber P, Kaltofen T, Heublein S, Kuhn C, Mayr D, Burges A, Mahner S, Rathert P, Jeschke U, Trillsch F.
    Front Endocrinol (Lausanne); 2021 May 12; 12():564002. PubMed ID: 33679613
    [Abstract] [Full Text] [Related]

  • 17. The Epithelial-Mesenchymal Transition, E-cadherin and Tumor Progression in Ovarian Serous Tumors.
    Bozhkova DM, Poryazova-Markova EG.
    Folia Med (Plovdiv); 2019 Jun 01; 61(2):296-302. PubMed ID: 31301662
    [Abstract] [Full Text] [Related]

  • 18. CD105/Ki67 coexpression correlates with tumor progression and poor prognosis in epithelial ovarian cancer.
    Liu P, Sun YL, Du J, Hou XS, Meng H.
    Int J Gynecol Cancer; 2012 May 01; 22(4):586-92. PubMed ID: 22266931
    [Abstract] [Full Text] [Related]

  • 19. Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer.
    Han GH, Chay DB, Nam S, Cho H, Chung JY, Kim JH.
    BMC Cancer; 2019 Dec 10; 19(1):1202. PubMed ID: 31823759
    [Abstract] [Full Text] [Related]

  • 20. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
    Zhang W, Niu C, He W, Hou T, Sun X, Xu L, Zhang Y.
    Tumour Biol; 2016 May 10; 37(5):6239-54. PubMed ID: 26615423
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.